Development and Clinical Application of ApoC3 Protein as a Predictive Biomarker for Insulin Resistance in Polycystic Ovary Syndrome
研究概览
研究类型
注册 (估计的)
联系人和位置
学习地点
-
-
-
Guangzhou、中国
- Guangdong Women and Children Hospital
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
接受健康志愿者
取样方法
研究人群
This study included PCOS patients diagnosed according to the 2003 Rotterdam criteria (at least 2 of: oligo/anovulation, clinical/biochemical hyperandrogenism, or polycystic ovaries on ultrasound). Patients were divided into two groups:
PCOS-IR group: met PCOS criteria plus at least one of: HOMA-IR ≥ 2.5, fasting insulin ≥ 15 μIU/mL, or diagnosed IGT/T2DM.
PCOS-non-IR group: met PCOS criteria with HOMA-IR < 2.5 and no glucose metabolism abnormalities.
Exclusion criteria: other endocrine disorders, medication use, severe systemic diseases, pregnancy/lactation, or poor sample quality.
描述
I. Diagnostic Criteria
The 2003 Rotterdam diagnostic criteria for PCOS jointly established by the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM):
Clinical and/or biochemical signs of hyperandrogenism; Oligo-ovulation or anovulation; Ultrasound findings: ovarian volume ≥ 10 mL, and/or > 12 follicles with a diameter of 2-9 mm in a single section.
A diagnosis of PCOS can be established when at least two of the following three criteria are met: ovarian dysfunction, hyperandrogenism, and polycystic ovarian morphology on ultrasound.
II. Inclusion and Exclusion Criteria
PCOS with Insulin Resistance (PCOS-IR)
Inclusion Criteria:
Meets the 2003 Rotterdam diagnostic criteria for PCOS (at least 2 of the following 3 items):
① Oligo-ovulation or anovulation;
② Clinical or biochemical signs of hyperandrogenism;
③ Polycystic ovaries on ultrasound (unilateral or ovarian volume ≥ 10 mL).
Insulin resistance (IR), meeting at least 1 of the following 3 criteria:
① HOMA-IR ≥ 2.5;
② Fasting insulin ≥ 15 μIU/mL;
③ Diagnosed impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM).
Exclusion Criteria:
Other endocrine disorders; Medication effects; Severe systemic diseases; Special physiological conditions (e.g., pregnancy, lactation); Poor sample quality.
- PCOS without Insulin Resistance (PCOS-non-IR)
Inclusion Criteria:
Meets the PCOS diagnostic criteria (as above), with HOMA-IR < 2.5 and no glucose metabolism abnormalities.
Exclusion Criteria: Same as above.
学习计划
研究是如何设计的?
设计细节
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
adverse pregnancy outcomes and long-term complications such as type 2 diabetes mellitus
大体时间:1year
|
1year
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.